Name | Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dime thyl-3,5-pyridinedicarboxylate |
Synonyms | CS-136 CLEVELOX Cleviprex CLEVIDIPINE Clevidipine butyrate Clevidipine, Cleviprex Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dime thyl-3,5-pyridinedicarboxylate 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-Pyridinedicarboxylic acid methyl (1-oxobutoxy)methyl ester 3,5-Pyridinedicarboxylicacid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl5-[(1-oxobutoxy)methyl] ester |
CAS | 167221-71-8 |
EINECS | 682-702-2 |
InChI | InChI=1/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3 |
Molecular Formula | C21H23Cl2NO6 |
Molar Mass | 456.32 |
Density | 1.289 |
Melting Point | 128-130°C |
Boling Point | 539.7±50.0 °C(Predicted) |
Flash Point | 280℃ |
Water Solubility | Insoluble in water |
Solubility | DMSO 91 mg/mL Water <1 mg/mL Ethanol 3 mg/mL |
Appearance | powder to crystal |
Color | White to Light yellow |
pKa | 2.45±0.70(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,2-8°C |
Use | A calcium channel protein inhibitor and blocker |
Safety Description | 24/25 - Avoid contact with skin and eyes. |
HS Code | 29339900 |